AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionMatthew Goff Investment Advisor, LLC
Latest Disclosed Ownership16,822 shares
Latest Disclosed Value $ 3,658,646
Matthew Goff Investment Advisor, LLC reports 2.27% decrease in ownership of ABBV / AbbVie Inc.

On April 17, 2026 - Matthew Goff Investment Advisor, LLC filed a 13F-HR form disclosing ownership of 16,822 shares of AbbVie Inc. (MX:ABBV) valued at $3,658,646 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 14, 2026 disclosing 17,212 shares of AbbVie Inc.. This represents a change in shares of -2.27% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F ABBVIE COM 00287Y109 16,822 -390 -2.27 3,659 -6.97 0.6099
2026-01-14 2025-12-31 13F ABBVIE COM 00287Y109 17,212 -349 -1.99 3,933 -3.30 0.6970
2025-10-15 2025-09-30 13F ABBVIE COM 00287Y109 17,561 45 0.26 4,066 25.07 0.6949
2025-07-11 2025-06-30 13F ABBVIE COM 00287Y109 17,516 0 0.00 3,251 -11.39 0.6014
2025-04-21 2025-03-31 13F ABBVIE COM 00287Y109 17,516 -39 -0.22 3,670 17.63 0.6769
2025-01-21 2024-12-31 13F ABBVIE COM 00287Y109 17,555 97 0.56 3,120 -9.52 0.5798
2024-10-17 2024-09-30 13F ABBVIE COM 00287Y109 17,458 -51 -0.29 3,448 14.79 0.6561
2024-07-22 2024-06-30 13F ABBVIE COM 00287Y109 17,509 0 0.00 3,003 -5.80 0.6129
2024-04-11 2024-03-31 13F ABBVIE COM 00287Y109 17,509 92 0.53 3,188 18.12 0.6455
2024-01-09 2023-12-31 13F ABBVIE COM 00287Y109 17,417 -110 -0.63 2,699 3.33 0.5988
2023-10-11 2023-09-30 13F ABBVIE COM 00287Y109 17,527 -78 -0.44 2,613 10.16 0.6288
2023-07-12 2023-06-30 13F ABBVIE COM 00287Y109 17,605 -67 -0.38 2,372 -15.80 0.5569
2023-04-13 2023-03-31 13F ABBVIE COM 00287Y109 17,672 -22 -0.12 2,816 -1.50 0.6989
2023-01-11 2022-12-31 13F ABBVIE COM 00287Y109 17,694 0 0.00 2,860 20.38 0.7453
2022-10-13 2022-09-30 13F ABBVIE COM 00287Y109 17,694 -13 -0.07 2,375 -12.43 0.6788
2022-07-22 2022-06-30 13F ABBVIE COM 00287Y109 17,707 -391 -2.16 2,712 -7.57 0.7302
2022-04-19 2022-03-31 13F ABBVIE COM 00287Y109 18,098 -36 -0.20 2,934 19.51 0.6885
2022-01-18 2021-12-31 13F ABBVIE COM 00287Y109 18,134 0 0.00 2,455 25.51 0.5624
2021-10-12 2021-09-30 13F ABBVIE COM 00287Y109 18,134 -15 -0.08 1,956 -4.31 0.4796
2021-07-22 2021-06-30 13F ABBVIE COM 00287Y109 18,149 0 0.00 2,044 4.07 0.5187
2021-04-21 2021-03-31 13F ABBVIE COM 00287Y109 18,149 -38 -0.21 1,964 0.77 0.5538
2021-01-27 2020-12-31 13F ABBVIE COM 00287Y109 18,187 -439 -2.36 1,949 19.50 0.5799
2020-10-29 2020-09-30 13F ABBVIE COM 00287Y109 18,626 -1,422 -7.09 1,631 -17.12 0.5205
2020-07-31 2020-06-30 13F ABBVIE COM 00287Y109 20,048 39 0.19 1,968 29.05 0.6456
2020-05-05 2020-03-31 13F ABBVIE COM 00287Y109 20,009 -312 -1.54 1,525 -15.23 0.6421
2020-01-27 2019-12-31 13F ABBVIE COM 00287Y109 20,321 -25 -0.12 1,799 16.74 0.6663
2019-11-07 2019-09-30 13F/A-1 ABBVIE COM 00287Y109 20,346 -774 -3.66 1,541 0.33 0.6365
2019-10-28 2019-09-30 13F AbbVie COM 00287Y109 1,541 -19,579 20,346
2019-08-05 2019-06-30 13F ABBVIE COM 00287Y109 21,120 0 0.00 1,536 -9.75 0.6575
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 21,120 0 0.00 1,702 -12.58 0.7851
2019-02-12 2018-12-31 13F ABBVIE COM 00287Y109 21,120 -294 -1.37 1,947 -3.85 0.9891
2018-12-06 2018-09-30 13F/A-2 ABBVIE COM 00287Y109 21,414 -2,615 -10.88 2,025 -9.03 0.8118
2018-11-21 2018-09-30 13F/A-1 ABBVIE COM 00287Y109 24,029 2,615 2,226 0.8698
2018-11-15 2018-09-30 13F ABBVIE COM 00287Y109 2,226,305 2,202,276 24,029
2018-08-13 2018-06-30 13F ABBVIE COM 00287Y109 24,029 -6,374 -20.97 2,226 -22.65 0.8707
2018-05-10 2018-03-31 13F ABBVIE COM 00287Y109 30,403 -451 -1.46 2,878 -3.55 1.2066
2018-02-13 2017-12-31 13F ABBVIE COM 00287Y109 30,854 -1,440 -4.46 2,984 3.97 1.2836
2017-11-08 2017-09-30 13F ABBVIE COM 00287Y109 32,294 -80 -0.25 2,870 22.28 1.2327
2017-08-10 2017-06-30 13F ABBVIE COM 00287Y109 32,374 -2,587 -7.40 2,347 3.03 2.1054
2017-05-12 2017-03-31 13F ABBVIE COM 00287Y109 34,961 34,961 2,278 2.1775
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.